相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Antibody-based immunotherapy targeting cytokines and atherothrombotic cardiovascular diseases
Hafid Ait-Oufella et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2020)
Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport
Jinque Luo et al.
FASEB JOURNAL (2020)
Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression
Monika Sharma et al.
CIRCULATION RESEARCH (2020)
The (inner) world according to GARP: Genetic susceptibility and regulatory T cells
Shiv Pillai
Science Immunology (2020)
Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer
Alessandra Metelli et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Inflammation, Superadded Inflammation, and Out-of-Proportion Inflammation in Atherosclerosis
Jagat Narula et al.
JAMA CARDIOLOGY (2018)
Structural basis of latent TGF-beta 1 presentation and activation by GARP on human regulatory T cells
Stephanie Lienart et al.
SCIENCE (2018)
Garp as a therapeutic target for modulation of T regulatory cell function
Ethan M. Shevach
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Role of GARP in the activation of latent TGF-β1
Julie Stockis et al.
MOLECULAR BIOSYSTEMS (2017)
Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
Andrew L. Mellor et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Impact of IL-17 in Atherosclerosis
Xinjie Lu
CURRENT MEDICINAL CHEMISTRY (2017)
Functional and homeostatic defects of regulatory T cells in patients with coronary artery disease
L. Hasib et al.
JOURNAL OF INTERNAL MEDICINE (2016)
IL-10/IFNγ co-expressing CD4+ T cells induced by IL-10 DC display a regulatory gene profile and downmodulate T cell responses
Martine A. Boks et al.
CLINICAL IMMUNOLOGY (2016)
GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing
Liping Sun et al.
ONCOTARGET (2016)
Interleukin-37 and Dendritic Cells Treated With Interleukin-37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction
Ruirui Zhu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
How Soluble GARP Enhances TGFβ Activation
Sven Fridrich et al.
PLOS ONE (2016)
Plasma IL-5 concentration and subclinical carotid atherosclerosis
Angela Silveira et al.
ATHEROSCLEROSIS (2015)
Dendritic Cells: A Double-Edge Sword in Atherosclerotic Inflammation
Dimitry A. Chistiakov et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Oxidized Low-Density Lipoprotein-Induced Apoptotic Dendritic Cells as a Novel Therapy for Atherosclerosis
Vanessa Frodermann et al.
JOURNAL OF IMMUNOLOGY (2015)
Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP
Xiaoqi Zhao et al.
MEDIATORS OF INFLAMMATION (2015)
T-Helper Type 1 Bias in Healthy People Is Associated With Cytomegalovirus Serology and Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis
Russell P. Tracy et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice
Fumitake Usui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
CD4+LAP+ and CD4+CD25+Foxp3+ Regulatory T Cells Induced by Nasal Oxidized Low-Density Lipoprotein Suppress Effector T Cells Response and Attenuate Atherosclerosis in ApoE-/- Mice
Yucheng Zhong et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Establishment of Nasal Tolerance to Heat Shock Protein-60 Alleviates Atherosclerosis by Inducing TGF-β-dependent Regulatory T Cells
Haiyu Li et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2012)
Immunotherapy With Tolerogenic Apolipoprotein B-100-Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic Mice
Andreas Hermansson et al.
CIRCULATION (2011)
Oral Administration of an Active Form of Vitamin D3 (Calcitriol) Decreases Atherosclerosis in Mice by Inducing Regulatory T Cells and Immature Dendritic Cells With Tolerogenic Functions
Masafumi Takeda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
The Tregs' world according to GARP
Manuela Battaglia et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg
Julie Stockis et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
GARP: a key receptor controlling FOXP3 in human regulatory T cells
M. Probst-Kepper et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Expression of GARP selectively identifies activated human FOXP3+regulatory T cells
Rui Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis
Adi Mor et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis
CJ Binder et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice
VL King et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)